NCT00342940View on ClinicalTrials.gov

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 31, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

influenza surface antigen inactivated vaccine

Trial Locations (1)

SL1 2AD

Chiltern International Limited , Chiltern Place, Upton Road, Slough

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY